Stockreport

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF – Served on Original Team Responsible for the Launch of Copaxone® in the United States – NEW YORK March 31, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late- [Read more]